In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.
Thirty-one percent of respondents to a Texas A&M-led survey said they don’t intend to be vaccinated against COVID-19.
Combustibility is likely a non-issue, but exposure to direct sunlight can degrade the ingredients in hand sanitizer, a Texas A&M physician says.
New positive cases and deaths appear to be slowing, but avoiding complacency will be critical as Texas continues its phased economic reopening.
A Texas A&M team received a National Science Foundation grant to pursue the 'lab-on-a-chip' technology to rapidly identify antibodies for therapeutics to fight COVID-19.
Classes at Texas A&M will begin Aug. 19 and end prior to Thanksgiving.
Virtual graduation celebrations and conferral of degrees are planned.
A Texas A&M mental health expert offers advice for reducing anxiety as Americans begin to return to work and daily routines during the COVID-19 pandemic.
Texas A&M experts examine which countries have responded effectively to the pandemic – and what the U.S. can learn from them.
As the health care community struggles to keep up with supply demands, Aggie makers and engineers are creating much-needed medical equipment.
The pandemic created a ‘perfect storm’ for many fruit and vegetable producers, Texas A&M AgriLife experts say.
As the pandemic was spreading, a Texas A&M University staff member jumped into action to get the student back from Alternative Spring Break within hours.